Evidence map›Paper›PMID 21212313›Full record

ArticleJournal of dental research2011

Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia.

M D McKee, Y Nakano, D L Masica, J J Gray, I Lemire, R Heft, M P Whyte, P Crine, J L Millán

Open access · greenAbstract read
In one paragraph

Article in Journal of dental research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 127 citations in OpenAlex.

  1. Article
  2. Hypophosphatasia-pathophysiological understanding, preclinical data looking beyond the skeleton, and upcoming treatments.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Review
  3. ENPP1 inhibition as a therapeutic approach for later-onset hypophosphatasia.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Establishment of human periodontal ligament cell lines withFrontiers in cell and developmental biology · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Dental manifestation and management of hypophosphatasia.The Japanese dental science review · 2022
    Review
  17. Review
  18. Article
  19. Prenatal enzyme replacement therapy forRegenerative therapy · 2021
    Article
  20. Gene Therapy Using Adeno-Associated Virus Serotype 8 Encoding TNAP-DJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

M D McKeeFaculty of Dentistry, and Department of Anatomy and Cell Biology, McGill University, Strathcona Anatomy and Dentistry Bldg, 3640 University Street, Montreal, Quebec, Canada. marc.mckee@mcgill.ca
Y Nakano
D L Masica
J J Gray
I Lemire
R Heft
M P Whyte
P Crine
J L Millán
Johns Hopkins University · USMcGill University · CASanford Burnham Prebys Medical Discovery Institute · USShriners Hospitals for Children - St. Louis · US

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Hypophosphatasia (HPP) occurs from loss-of-function mutation in the tissue-non-specific alkaline phosphatase (TNALP) gene, resulting in extracellular pyrophosphate accumulation that inhibits skeletal and dental mineralization. TNALP-null mice (Akp2(-/-)) phenocopy human infantile hypophosphatasia; they develop rickets at 1 week of age, and die before being weaned, having severe skeletal and dental hypomineralization and episodes of apnea and vitamin B(6)-responsive seizures. Delay and defects in dentin mineralization, together with a deficiency in acellular cementum, are characteristic. We report the prevention of these dental abnormalities in Akp2(-/-) mice receiving treatment from birth with daily injections of a mineral-targeting, human TNALP (sALP-FcD(10)). sALP-FcD(10) prevented hypomineralization of alveolar bone, dentin, and cementum as assessed by micro-computed tomography and histology. Osteopontin--a marker of acellular cementum--was immuno-localized along root surfaces, confirming that acellular cementum, typically missing or reduced in Akp2(-/-) mice, formed normally. Our findings provide insight concerning how acellular cementum is formed on tooth surfaces to effect periodontal ligament attachment to retain teeth in their osseous alveolar sockets. Furthermore, they provide evidence that this enzyme-replacement therapy, applied early in post-natal life--where the majority of tooth root development occurs, including acellular cementum formation--could prevent the accelerated tooth loss seen in individuals with HPP.

Indexed as

Enzyme Replacement TherapyAlkaline PhosphataseAlveolar ProcessAnimalsAnimals, NewbornCalcification, PhysiologicCementogenesisCrystallographyDental CementumDentinDisease Models, AnimalDurapatiteHumansHypophosphatasiaImmunohistochemistryMiceAlkaline PhosphataseALPL protein, humanALPL protein, mouseDurapatiteOsteopontinSpp1 protein, mouse

Identifiers

PMID21212313
PMCPMC3144124
OpenAlexW2071465976

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.